Astrazeneca (AZN) EPS (Diluted) (2009 - 2025)
Astrazeneca (AZN) recorded EPS (Diluted) of $1.85 in Q2 2026, down 18.6% from $2.28 a year earlier and down 6.1% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EPS (Diluted) (2009 - 2025) Analysis & Trends
On a TTM basis, Astrazeneca's EPS (Diluted) came in at $6.96 as of Jun 30, 2026, up 2.4% year-over-year; for FY2025, it came in at $6.55, up 45.4% from FY2024.
- Annual EPS (Diluted) has increased for three straight years, with a five-year compound annual growth rate of 21.9% (FY2020 to FY2025).
- Across earlier years, EPS (Diluted) came in at $4.50 in FY2024 (+18.1%), $3.81 in FY2023 (+80.9%), $2.11 in FY2022 and $0.08 in FY2021 (-96.8%).
- Quarterly EPS (Diluted) has ranged from -$1.51 in Q3 2021 to $2.28 in Q2 2025 over the past five years.
- On a year-over-year basis, EPS (Diluted) rose in five of the last eight quarters, with growth averaging 35.5%.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 392.6% in Q1 2023, against a decline of 76.1% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.97 (Q1 2026), $1.49 (Q4 2025) and $1.65 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 22.95 |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 11.03 |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.38 |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 7.28 |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.15 |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 6.55 |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 14.23 |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 6.78 |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 1.36 |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 15.32 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.55 |
| Dec 31, 2024 | 4.50 |
| Dec 31, 2023 | 3.81 |
| Dec 31, 2022 | 2.11 |
| Nov 10, 2022 | 1.68 |
| Dec 31, 2021 | 0.08 |
| Dec 31, 2020 | 2.43 |
| Dec 31, 2019 | 1.03 |
| Dec 31, 2018 | 1.70 |
| Dec 31, 2017 | 2.37 |
| Dec 31, 2016 | 2.76 |
| Mar 5, 2016 | 2.69 |
| Dec 31, 2015 | 2.23 |
| Mar 6, 2015 | 1.80 |
| Dec 31, 2014 | -1.46 |
| Apr 24, 2014 | 0.94 |
| Dec 31, 2013 | -0.60 |
| Dec 31, 2012 | 1.67 |
| May 10, 2012 | 1.48 |
| Dec 31, 2011 | 3.93 |
API Access
Astrazeneca EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted-annual&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted-annual", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted-annual&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();